Company Research Report: OMINI

Company Overview

• Name: OMINI

• Mission: Transforming the lives of patients suffering from chronic diseases through connected blood testing technology.

• Founded: No specific founding year mentioned, though context suggests activity around recent years.

• Founders: Joanne Kanaan, Ph.D (CEO) and Anna Shirinskaya, Ph.D (CTO)

• Key People:

• Joanne Kanaan, Ph.D – CEO and Cofounder

• Anna Shirinskaya, Ph.D – CTO and Cofounder

• Katlin Rohtlaid, Ph.D – Senior Researcher in Material Science

• Jean-Francois Arruabarrena – Lead Industrial Designer

• Pascal Preira, Ph.D – Senior Researcher in Biology and Sensor Functionalization

• Clara Dos Santos – Doctoral Student, Sensor Development

• Arielle N'Da – Junior Researcher

• Alain Marty – Engineer in Microelectronics

• Headquarters: No information is available

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Developing portable, connected blood testing technology aimed at improving chronic disease management.

Products

• Product Offered: A compact blood testing lab and multiplex testing strips.

• High-Level Description: The company's primary product combines a portable, connected reader with an array of multiplex blood testing strips. The device is designed to be as user-friendly as a glucometer and can be carried in a pocket. Each strip is capable of diagnosing specific disease-related blood biomarkers.

• Key Features:

• Decentralized Testing: Allows testing and monitoring at the point of care.

• Multiplex Strips: Capable of simultaneously measuring multiple biomarkers from a single blood sample.

• Modular Design: Allows modification to test a variety of biomarkers.

• Early Detection: Detects changes in biomarker levels before clinical symptoms manifest.

• Personalized Treatment: Tailored profiles for each patient improve treatment effectiveness.

Recent Developments

• Recent Developments:

• OMINI is pioneering a new approach in patient care for chronic diseases with their biosensor technology.

• Developing a specialized testing strip for heart failure patients that simultaneously measures four key biomarkers.

• New Products Launched: No specific recent product launches mentioned.

• New Features Added to Existing Products: Focus on improving heart failure patient outcomes and processes.

• New Partnerships: No information is available on new partnerships.

This report comprehensively covers available data about OMINI, focusing strictly on the details provided while noting areas where data is unavailable.